¹û¶³Ó°Ôº

Go to Other Outputs

Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial.Ìý (2019) Wademan, D. T., L. Busakwe, T. J. Nicholson, M. van der Zalm, M. Palmer, J. Workman, A. Turkova, A. M. Crook, J. Thomason, D. M. Gibb, J. Seeley, A. Hesseling and G. HoddinottÌý Int J Tuberc Lung Dis 23(12): 1263-1268 .

Advanced immunodiagnostic tests for paediatric tuberculosis.Ìý (2019) Villanueva, P., E. Sudbury, R. Song, M. Tebruegge and N. CurtisÌý Lancet Infect Dis 19(5): 467-468 Ìý.

Advances in molecular diagnostic testing for central nervous system infections.Ìý (2019) Houlihan, C. F., T. Bharucha and J. BreuerÌý Curr Opin Infect Dis 32(3): 244-250 .

After the UNGA High-Level Meeting on Tuberculosis-what next and how?Ìý (2019) Sahu, S., L. Ditiu and A. ZumlaÌý Lancet Glob Health 7(5): e558-e560 .

App-based symptoms screening with Xpert MTB/RIF Ultra assay used for active tuberculosis detection in migrants at point of arrivals in Italy: The E-DETECT TB intervention analysis.Ìý (2019) Barcellini, L., E. Borroni, C. Cimaglia, E. Girardi, A. Matteelli, V. Marchese, G. Stancanelli, I. Abubakar, E. D. T. B. C. members of the and D. M. CirilloÌý PLoS One 14(7): e0218039 .

Application of machine learning techniques to tuberculosis drug resistance analysis.Ìý (2019) Kouchaki, S., Y. Yang, T. M. Walker, A. Sarah Walker, D. J. Wilson, T. E. A. Peto, D. W. Crook, C. R. Consortium and D. A. CliftonÌý Bioinformatics 35(13): 2276-2282 .

Assessment of the use and need for an integrated molecular surveillance of tuberculosis: an online survey in Germany.Ìý (2019) Sanchini, A., M. Andres, L. Fiebig, S. Albrecht, B. Hauer and W. HaasÌý BMC Public Health 19(1): 321 .

Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: Prevalence from screening of entrant and resident prisoners.Ìý (2019) Tsegaye Sahle, E., J. Blumenthal, S. Jain, S. Sun, J. Young, T. Manyazewal, H. Woldeamanuel, L. Teferra, B. Feleke, O. Vandenberg, Z. Rey, M. Briggs-Hagen, R. Haubrich, W. Amogne and J. A. McCutchanÌý PLoS One 14(12): e0226160 .

BCG vaccination following latent TB treatment: Possible implications for different settings.Ìý (2019) Gosce, L., J. Bitencourt, R. K. Gupta, S. Arruda, L. C. Rodrigues and I. AbubakarÌý Int J Infect Dis 80S: S17-S19 .

Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial.Ìý (2019) Tweed, C. D., R. Dawson, D. A. Burger, A. Conradie, A. M. Crook, C. M. Mendel, F. Conradie, A. H. Diacon, N. E. Ntinginya, D. E. Everitt, F. Haraka, M. Li, C. H. van Niekerk, A. Okwera, M. S. Rassool, K. Reither, M. A. Sebe, S. Staples, E. Variava and M. SpigelmanÌý Lancet Respir Med 7(12): 1048-1058 .

Blood transcriptomic stratification of short-term risk in contacts of tuberculosis.Ìý (2019) Roe, J., C. Venturini, R. K. Gupta, C. Gurry, B. M. Chain, Y. Sun, J. Southern, C. Jackson, M. C. Lipman, R. F. Miller, A. R. Martineau, I. Abubakar and M. NoursadeghiÌý Clin Infect Dis .

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.Ìý (2019) Lamb, C. A., N. A. Kennedy, T. Raine, P. A. Hendy, P. J. Smith, J. K. Limdi, B. Hayee, M. C. E. Lomer, G. C. Parkes, C. Selinger, K. J. Barrett, R. J. Davies, C. Bennett, S. Gittens, M. G. Dunlop, O. Faiz, A. Fraser, V. Garrick, P. D. Johnston, M. Parkes, J. Sanderson, H. Terry, I. B. D. g. e. c. group, D. R. Gaya, T. H. Iqbal, S. A. Taylor, M. Smith, M. Brookes, R. Hansen and A. B. HawthorneÌý Gut 68(Suppl 3): s1-s106 .

Building a European database to gather multi-country evidence on active and latent TB screening for migrants.Ìý (2019) Ohd, J. N., K. Lonnroth, I. Abubakar, R. W. Aldridge, C. Erkens, J. Jonsson, V. Marchese, A. Matteelli, D. Menezes, D. Zenner and M. P. HergensÌý Int J Infect Dis 80S: S45-S49 .

The burden of latent multidrug-resistant tuberculosis.Ìý (2019) Garcia-Basteiro, A. L., H. E. Jenkins and M. RangakaÌý Lancet Infect Dis 19(8): 802-803 .

Burden of multidrug-resistant tuberculosis in England: a focus on prevalent cases.Ìý (2019) Lalor, M. K., S. Perkins and H. L. ThomasÌý Int J Tuberc Lung Dis 23(6): 707-713 .

Calcineurin Inhibitors and Variation in the Performance of Interferon-gamma Release Assays Used to Detect Tuberculosis Infection.Ìý (2019) Barton, E., Y. Gao, D. Ball, K. Fidler, N. Klein, N. Curtis, V. Clifford, B. G. Marshall, A. Chancellor, S. Mansour, P. Elkington and M. TebrueggeÌý Ann Am Thorac Soc 16(6): 771-775 .

Can phenotypic data complement our understanding of antimycobacterial effects for drug combinations?Ìý (2019) Kloprogge, F., R. Hammond, A. Copas, S. H. Gillespie and O. Della PasquaÌý J Antimicrob Chemother 74(12): 3530-3536 .

Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles' heel for the TB-causing pathogen.Ìý (2019) Maitra, A., T. Munshi, J. Healy, L. T. Martin, W. Vollmer, N. H. Keep and S. BhaktaÌý FEMS Microbiol Rev 43(5): 548-575 .

The Changing Landscape of Childhood Tuberculosis in the United Kingdom: A Retrospective Cohort (2000-2015).Ìý (2019) Mohiyuddin, T., J. A. Seddon, H. L. Thomas and M. K. LalorÌý Pediatr Infect Dis J 38(5): 470-475 .

The changing treatment landscape for MDR/XDR-TB - Can current clinical trials revolutionise and inform a brave new world?Ìý (2019) Honeyborne, I., M. Lipman, A. Zumla and T. D. McHughÌý Int J Infect Dis 80S: S23-S28 .

Children With Cystic Fibrosis Are Infected With Multiple Subpopulations of Mycobacterium abscessus With Different Antimicrobial Resistance Profiles.Ìý (2019) Shaw, L. P., R. M. Doyle, E. Kavaliunaite, H. Spencer, F. Balloux, G. Dixon and K. A. HarrisÌý Clin Infect Dis 69(10): 1678-1686 .

Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1.Ìý (2019) Carey, B., J. Lambourne, S. Porter and T. HodgsonÌý Oral Dis 25(3): 684-692 .

Clinical utility of existing and second-generation interferon-gamma release assays for diagnostic evaluation of tuberculosis: an observational cohort study.Ìý (2019) Whitworth, H. S., A. Badhan, A. A. Boakye, Y. Takwoingi, M. Rees-Roberts, C. Partlett, H. Lambie, J. Innes, G. Cooke, M. Lipman, C. Conlon, D. Macallan, F. Chua, F. A. Post, M. Wiselka, G. Woltmann, J. J. Deeks, O. M. Kon, A. Lalvani and g. Interferon-gamma Release Assays for Diagnostic Evaluation of Active Tuberculosis studyÌý Lancet Infect Dis 19(2): 193-202 .

Community-based testing of migrants for infectious diseases (COMBAT-ID): impact, acceptability and cost-effectiveness of identifying infectious diseases among migrants in primary care: protocol for an interrupted time-series, qualitative and health economic analysis.Ìý (2019) Pareek, M., H. C. Eborall, F. Wobi, K. S. Ellis, E. Kontopantelis, F. Zhang, R. Baggaley, T. D. Hollingsworth, D. Baines, H. Patel, P. Haldar, M. Patel, I. Stephenson, I. Browne, P. Gill, R. Kapur, A. Farooqi, I. Abubakar and C. GriffithsÌý BMJ Open 9(3): e029188 .

Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation.Ìý (2019) Bogdanova, E. N., A. O. Mariandyshev, G. A. Balantcev, P. I. Eliseev, E. I. Nikishova, A. I. Gaida, D. Enarson, A. Detjen, R. Dacombe, P. P. J. Phillips, S. B. Squire and E. GospodarevskayaÌý PLoS One 14(1): e0211203 .

Cross-transmission is not the source of new Mycobacterium abscessus infections in a multi-centre cohort of cystic fibrosis patients.Ìý (2019) Doyle, R. M., M. Rubio, G. Dixon, J. Hartley, N. Klein, P. Coll and K. A. HarrisÌý Clin Infect Dis .

Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting.Ìý (2019) Clifford, V., M. Tebruegge, C. Zufferey, S. Germano, B. Forbes, L. Cosentino, E. Matchett, E. McBryde, D. Eisen, R. Robins-Browne, A. Street, J. Denholm and N. CurtisÌý Tuberculosis (Edinb) 114: 91-102 .

Developing a pathway for the diagnosis and management of ocular tuberculosis. The pan-LOndon Ocular tuberculosis Pathway-LOOP.Ìý (2019) Petrushkin, H., C. Sethi, J. Potter, L. Martin, G. Russell, V. White, S. Ajamil-Rodanes, M. Brown, R. Breen, M. Lipman, I. Cropley, R. McDermott, A. Roche, H. Booth, J. Milburn, M. Darmalingam, R. Lee, C. Pavesio, M. Stanford, O. M. Kon and G. BothamleyÌý Eye (Lond) .

Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort.Ìý (2019) Jackson, C., J. Southern, A. Lalvani, F. Drobniewski, C. J. Griffiths, M. Lipman, G. H. Bothamley, J. J. Deeks, A. Imran, O. M. Kon, S. Mpofu, V. Nikolayevskyy, M. Rees-Roberts, A. Sitch, S. Sridhar, C. Y. Tsou, H. Whitworth and I. AbubakarÌý Thorax 74(1): 91-94 .

Diagnostic Bacteriology in District Hospitals in Sub-Saharan Africa: At the Forefront of the Containment of Antimicrobial Resistance.Ìý (2019) Jacobs, J., L. Hardy, M. Semret, O. Lunguya, T. Phe, D. Affolabi, C. Yansouni and O. VandenbergÌý Front Med (Lausanne) 6: 205 .

Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children.Ìý (2019) Muenchhoff, M., E. Adland, J. Roider, H. Kloverpris, A. Leslie, S. Boehm, O. T. Keppler, T. Ndung'u and P. J. R. GoulderÌý J Infect Dis 219(9): 1407-1417 .

Discordance in latent tuberculosis (TB) test results in patients with end-stage renal disease.Ìý (2019) Southern, J., S. Sridhar, C. Y. Tsou, S. Hopkins, S. Collier, V. Nikolayevskyy, S. Lozewicz, A. Lalvani, I. Abubakar and M. LipmanÌý Public Health 166: 34-39 .

Does sexual behaviour of people with HIV reflect antiretroviral therapy as a preventive strategy? A cross-sectional study among outpatients in Kenya.Ìý (2019) Nkhoma, K., A. Ahmed, Z. Alli, L. Sherr and R. HardingÌý BMC Public Health 19(1): 1254 .

Dual RNA-Seq of Human Leprosy Lesions Identifies Bacterial Determinants Linked to Host Immune Response.Ìý (2019) Montoya, D. J., P. Andrade, B. J. A. Silva, R. M. B. Teles, F. Ma, B. Bryson, S. Sadanand, T. Noel, J. Lu, E. Sarno, K. B. Arnvig, D. Young, R. Lahiri, D. L. Williams, S. Fortune, B. R. Bloom, M. Pellegrini and R. L. ModlinÌý Cell Rep 26(13): 3574-3585 e3573 .

Effectiveness of interventions for reducing TB incidence in countries with low TB incidence: a systematic review of reviews.Ìý (2019) Collin, S. M., F. Wurie, M. C. Muzyamba, G. de Vries, K. Lonnroth, G. B. Migliori, I. Abubakar, S. R. Anderson and D. ZennerÌý Eur Respir Rev 28(152) .

Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study.Ìý (2019) Berrocal-Almanza, L. C., R. Harris, M. K. Lalor, M. C. Muzyamba, J. Were, A. M. O'Connell, A. Mirza, O. M. Kon, A. Lalvani and D. ZennerÌý Lancet Infect Dis 19(11): 1191-1201 .

Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. (2019) Dedrick, R. M., C. A. Guerrero-Bustamante, R. A. Garlena, D. A. Russell, K. Ford, K. Harris, K. C. Gilmour, J. Soothill, D. Jacobs-Sera, R. T. Schooley, G. F. Hatfull and H. Spencer. Nat Med 25(5): 730-733

Etiology and Risk Factors for Mortality in an Adult Community-acquired Pneumonia Cohort in Malawi.Ìý (2019) Aston, S. J., A. Ho, H. Jary, J. Huwa, T. Mitchell, S. Ibitoye, S. Greenwood, E. Joekes, A. Daire, J. Mallewa, D. Everett, M. Nyirenda, B. Faragher, H. C. Mwandumba, R. S. Heyderman and S. B. GordonÌý Am J Respir Crit Care Med 200(3): 359-369 .

Evaluations of clinical tobacco cessation interventions in Arab populations: A systematic review.Ìý (2019) Alzahrane, A., R. West, H. K. Ubhi, J. Brown, N. Abdulqader and O. SamarkandiÌý Addict Behav 88: 169-174 .

Evidence for supercoughers in an analysis of six tuberculosis cohorts from China, Peru, The Gambia and Uganda.Ìý (2019) Handel, A., L. Martinez, J. N. Sekandi, S. E. Bellan, L. Zhu, C. Chen, Q. Liu, S. Donkor, J. Sutherland, P. C. Hill, R. H. Gilman, L. Grandjean and C. C. WhalenÌý Int J Tuberc Lung Dis 23(12): 1286-1292 .

Exploring the effects of BCG vaccination in patients diagnosed with tuberculosis: Observational study using the Enhanced Tuberculosis Surveillance system.Ìý (2019) Abbott, S., H. Christensen, M. K. Lalor, D. Zenner, C. Campbell, M. E. Ramsay and E. Brooks-PollockÌý Vaccine 37(35): 5067-5072 .

Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance.Ìý (2019) Stagg, H. R., G. H. Bothamley, J. A. Davidson, H. Kunst, M. K. Lalor, M. C. Lipman, M. G. Loutet, S. Lozewicz, T. Mohiyuddin, A. Abbara, E. Alexander, H. Booth, D. D. Creer, R. J. Harris, O. M. Kon, M. R. Loebinger, T. D. McHugh, H. J. Milburn, P. Palchaudhuri, P. P. J. Phillips, E. Schmok, L. Taylor, I. Abubakar and I. N. H. R. T. B. s. g. LondonÌý Eur Respir J 54(4) .

Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.Ìý (2019) Ardain, A., R. Domingo-Gonzalez, S. Das, S. W. Kazer, N. C. Howard, A. Singh, M. Ahmed, S. Nhamoyebonde, J. Rangel-Moreno, P. Ogongo, L. Lu, D. Ramsuran, M. de la Luz Garcia-Hernandez, K. U. T, M. Darby, E. Park, F. Karim, L. Melocchi, R. Madansein, K. J. Dullabh, M. Dunlap, N. Marin-Agudelo, T. Ebihara, T. Ndung'u, D. Kaushal, A. S. Pym, J. K. Kolls, A. Steyn, J. Zuniga, W. Horsnell, W. M. Yokoyama, A. K. Shalek, H. N. Kloverpris, M. Colonna, A. Leslie and S. A. KhaderÌý Nature 570(7762): 528-532 .

High-income countries and latent tuberculosis infection screening for migrants - Authors' reply.Ìý (2019) Petersen, E., J. Chakaya, F. M. Jawad, G. Ippolito and A. ZumlaÌý Lancet Infect Dis 19(7): 691-692 .

HIV, Tuberculosis, and Otogenic Intracranial Sepsis: A Devastating Disease With a Subtle Presentation.Ìý (2019) Yakobi, A., J. Z. Porterfield, J. Toman, T. Spock, N. Kapil, J. de Meyer, A. Kejner, P. Rea, M. Gleeson, B. Enicker, E. Michaelides and Y. SamanÌý Otol Neurotol 40(7): e704-e712 .

Identification and characterization of a novel anti-inflammatory lipid isolated from Mycobacterium vaccae, a soil-derived bacterium with immunoregulatory and stress resilience properties.Ìý (2019) Smith, D. G., R. Martinelli, G. S. Besra, P. A. Illarionov, I. Szatmari, P. Brazda, M. A. Allen, W. Xu, X. Wang, L. Nagy, R. D. Dowell, G. A. W. Rook, L. Rosa Brunet and C. A. LowryÌý Psychopharmacology (Berl) 236(5): 1653-1670 .

IMPACT study on intervening with a manualised package to achieve treatment adherence in people with tuberculosis: protocol paper for a mixed-methods study, including a pilot randomised controlled trial.Ìý (2019) Stagg, H. R., I. Abubakar, C. N. Campbell, A. Copas, M. Darvell, R. Horne, K. Kielmann, H. Kunst, M. Mandelbaum, E. Pickett, A. Story, N. Vidal, F. B. Wurie and M. LipmanÌý BMJ Open 9(12): e032760 .

Improving access to contraception through integration of family planning services into a multidrug-resistant tuberculosis treatment programme.Ìý (2019) Cornish, E. F., J. Hudson, R. Sayers and M. LovedayÌý BMJ Sex Reprod Health .

Improving treatment outcomes for MDR-TB - Novel host-directed therapies and personalised medicine of the future.Ìý (2019) Rao, M., G. Ippolito, S. Mfinanga, F. Ntoumi, D. Yeboah-Manu, C. Vilaplana, A. Zumla and M. MaeurerÌý Int J Infect Dis 80S: S62-S67 .

Individualising therapy for drug-sensitive tuberculosis.Ìý (2019) Esmail, H., M. C. Lipman, A. Nunn and T. M. WalkerÌý Lancet Respir Med 7(10): 834-835 .

Integrated Target-Based and Phenotypic Screening Approaches for the Identification of Anti-Tubercular Agents That Bind to the Mycobacterial Adenylating Enzyme MbtA.Ìý (2019) Ferguson, L., G. Wells, S. Bhakta, J. Johnson, J. Guzman, T. Parish, R. A. Prentice and F. BrucoliÌý ChemMedChem 14(19): 1735-1741 .

Interferon-gamma release assays have suboptimal sensitivity in both latent and active tuberculosis.Ìý (2019) Goetzinger, F., I. Burkhardt, P. Villanueva, V. Clifford, N. Curtis and M. TebrueggeÌý Int J Tuberc Lung Dis 23(6): 766-767 .

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.Ìý (2019) Phillips, P. P. J., C. D. Mitnick, J. D. Neaton, P. Nahid, C. Lienhardt and A. J. NunnÌý PLoS Med 16(3): e1002767 .

Kidney disease in Africans with HIV and tuberculosis.Ìý (2019) Wearne, N., R. Hung, R. Bohmer, R. Spies, A. Omar, S. Ash, F. Ibrahim, R. F. Miller, J. W. Booth, S. B. Lucas and F. A. PostÌý AIDS 33(7): 1207-1213 .

Latent TB Infection (LTBI) - Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground.Ìý (2019) Rao, M., G. Ippolito, S. Mfinanga, F. Ntoumi, D. Yeboah-Manu, C. Vilaplana, A. Zumla and M. MaeurerÌý Int J Infect Dis 80S: S58-S61 .

Latent tuberculosis infection and renal transplantation - Diagnosis and management.Ìý (2019) Krishnamoorthy, S., N. Kumaresan and A. ZumlaÌý Int J Infect Dis 80S: S73-S76 .

Latent tuberculosis infection: diagnostic tests and when to treat.Ìý (2019) Petersen, E., J. Chakaya, F. M. Jawad, G. Ippolito and A. ZumlaÌý Lancet Infect Dis 19(3): 231-233 .

Linezolid for drug-susceptible tuberculosis.Ìý (2019) Ahmed, S., D. A. Moore, C. Nimmo, A. J. Nunn, T. A. Yates and T. B. J. C. North LondonÌý Lancet Infect Dis 19(4): 357 .

Longitudinal analysis of serum cytokine profile among patients with tubercular multifocal serpiginoid choroiditis: a pilot study.Ìý (2019) Agarwal, A., A. Deokar, R. Sharma, N. Singh, K. Aggarwal, S. Sharma, R. Singh, A. Sharma, K. Sharma, R. Agrawal, R. Bansal and V. GuptaÌý Eye (Lond) 33(1): 129-135 .

Lung Tissue Resident Memory T-Cells in the Immune Response to Mycobacterium tuberculosis.Ìý (2019) Ogongo, P., J. Z. Porterfield and A. LeslieÌý Front Immunol 10: 992 .

Million Migrants study of healthcare and mortality outcomes in non-EU migrants and refugees to England: Analysis protocol for a linked population-based cohort study of 1.5 million migrants.Ìý (2019) Burns, R., N. Pathak, I. Campos-Matos, D. Zenner, S. Vittal Katikireddi, M. C. Muzyamba, J. J. Miranda, R. Gilbert, H. Rutter, L. Jones, E. Williamson, A. C. Hayward, L. Smeeth, I. Abubakar, H. Hemingway and R. W. AldridgeÌý Wellcome Open Res 4: 4 .

Mimicking in-vivo exposures to drug combinations in-vitro: anti-tuberculosis drugs in lung lesions and the hollow fiber model of infection.Ìý (2019) Kloprogge, F., R. Hammond, K. Kipper, S. H. Gillespie and O. Della PasquaÌý Sci Rep 9(1): 13228 .

Multidrug and Extensively Drug-resistant Tuberculosis: Epidemiology, Clinical Features, Management and Treatment.Ìý (2019) Tiberi, S., A. Zumla and G. B. MiglioriÌý Infect Dis Clin North Am 33(4): 1063-1085 .

Multidrug-resistant tuberculosis.Ìý (2019) Nyang'wa, B. T., C. Berry, K. Fielding and A. J. NunnÌý Lancet 394(10195): 298-299 .

Mycobacteria-Specific Mono- and Polyfunctional CD4+ T Cell Profiles in Children With Latent and Active Tuberculosis: A Prospective Proof-of-Concept Study.Ìý (2019) Tebruegge, M., N. Ritz, S. Donath, B. Dutta, B. Forbes, V. Clifford, C. Zufferey, R. De Rose, R. M. Robins-Browne, W. Hanekom, S. M. Graham, T. Connell and N. CurtisÌý Front Immunol 10: 431 .

Mycobacterium tuberculosis transmission in an ethnically-diverse high incidence region in England, 2007-11.Ìý (2019) Vynnycky, E., A. R. Keen, J. T. Evans, S. Khanom, P. M. Hawkey, R. G. White and I. AbubakarÌý BMC Infect Dis 19(1): 26 .

Mycobacterium tuberculosis-specific cytokine biomarkers for the diagnosis of childhood TB in a TB-endemic setting.Ìý (2019) Sudbury, E. L., L. Otero, M. Tebruegge, N. L. Messina, C. Seas, M. Montes, J. Rios, S. Germano, K. Gardiner, V. Clifford, E. Gotuzzo and N. CurtisÌý J Clin Tuberc Other Mycobact Dis 16: 100102 .

New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease.Ìý (2019) Lee, S. F. K., B. E. Laughon, T. D. McHugh and M. LipmanÌý Curr Opin Pulm Med 25(3): 271-280 .

Osteoarcheological and biomolecular evidence of leprosy from an 11-13(th) century CE Muslim cemetery in Europe (Oroshaza, Southeast Hungary).Ìý (2019) Balazs, J., Z. Rozsa, Z. Bereczki, A. Marcsik, B. Tihanyi, K. Karlinger, G. Poloskei, E. Molnar, H. D. Donoghue and G. PalfiÌý Homo 70(2): 105-118 .

The pathogenesis of tuberculous meningitis.Ìý (2019) Davis, A. G., U. K. Rohlwink, A. Proust, A. A. Figaji and R. J. WilkinsonÌý J Leukoc Biol 105(2): 267-280 .

PET/CT features of Extrapulmonary Tuberculosis at first clinical presentation - a cross-sectional observational (18)F-FDG imaging study across six countries.Ìý (2019) Bomanji, J., R. Sharma, B. R. Mittal, S. Gambhir, A. Qureshy, S. M. F. Begum, D. Paez, M. Sathekge, M. Vorster, D. Sobic Saranovic, P. Pusuwan, V. Mann, S. Vinjamuri, A. Zumla, T. N. B. Pascual and T. B. C. International Atomic Energy Agency Extra-pulmonaryÌý Eur Respir J .

Plasma Biomarkers to Detect Prevalent or Predict Progressive Tuberculosis Associated With Human Immunodeficiency Virus-1.Ìý (2019) Lesosky, M., M. X. Rangaka, C. Pienaar, A. K. Coussens, R. Goliath, S. Mathee, J. Mwansa-Kambafwile, G. Maartens, R. J. Wilkinson and K. A. WilkinsonÌý Clin Infect Dis 69(2): 295-305 .

Prevalence, Safety and Long-Term Retention Rates of Biologics in Hong Kong from 2001 to 2015.Ìý (2019) Ge, M., K. K. Man, C. S. Chui, E. W. Chan, I. C. Wong and X. LiÌý Drug Saf 42(9): 1091-1102 .

Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting.Ìý (2019) Kendall, E. A., A. S. Azman, G. Maartens, A. Boulle, R. J. Wilkinson, D. W. Dowdy and M. X. RangakaÌý AIDS 33(3): 525-536 .

Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial.Ìý (2019) Burman, M., A. Copas, D. Zenner, V. Hickson, L. Gosce, D. Trathen, R. Ashcroft, A. R. Martineau, I. Abubakar, C. Griffiths and H. KunstÌý BMC Public Health 19(1): 1598 .

Public health outcome of Tuberculosis Cluster Investigations, England 2010-2013.Ìý (2019) Hamblion, E. L., A. Burkitt, M. K. Lalor, L. F. Anderson, H. L. Thomas, I. Abubakar, S. Morton, H. Maguire, S. R. Anderson and T. B. S. T. B. Public Health EnglandÌý J Infect 78(4): 269-274 .

Publisher Correction: Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.Ìý (2019) Ardain, A., R. Domingo-Gonzalez, S. Das, S. W. Kazer, N. C. Howard, A. Singh, M. Ahmed, S. Nhamoyebonde, J. Rangel-Moreno, P. Ogongo, L. Lu, D. Ramsuran, M. de la Luz Garcia-Hernandez, T. K. Ulland, M. Darby, E. Park, F. Karim, L. Melocchi, R. Madansein, K. J. Dullabh, M. Dunlap, N. Marin-Agudelo, T. Ebihara, T. Ndung'u, D. Kaushal, A. S. Pym, J. K. Kolls, A. Steyn, J. Zuniga, W. Horsnell, W. M. Yokoyama, A. K. Shalek, H. N. Kloverpris, M. Colonna, A. Leslie and S. A. KhaderÌý Nature 572(7768): E10 .

Quantitative Interferon Gamma Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis: A Prospective Cohort Study.Ìý (2019) Gupta, R. K., M. Lipman, C. Jackson, A. Sitch, J. Southern, F. Drobniewski, J. J. Deeks, C. Y. Tsou, C. Griffiths, J. Davidson, C. Campbell, O. Stirrup, M. Noursadeghi, H. Kunst, P. Haldar, A. Lalvani and I. AbubakarÌý Am J Respir Crit Care Med .

Recent Changes in Infectious Diseases in European Wildlife.Ìý (2019) Yon, L., J. P. Duff, E. O. Agren, K. Erdelyi, E. Ferroglio, J. Godfroid, J. Hars, G. Hestvik, D. Horton, T. Kuiken, A. Lavazza, I. Markowska-Daniel, A. Martel, A. Neimanis, F. Pasmans, S. J. Price, F. Ruiz-Fons, M. P. Ryser-Degiorgis, F. Widen and D. Gavier-WidenÌý J Wildl Dis 55(1): 3-43 .

Reducing loss to follow-up during treatment for drug-resistant tuberculosis.Ìý (2019) Abubakar, I. and M. LipmanÌý Eur Respir J 53(1) .

Revolutionary new treatment for multidrug-resistant tuberculosis.Ìý (2019) Meredith, S., A. Nunn and I. D. RussenÌý Lancet Infect Dis 19(6): 576-577 .

Revolutionary new treatment regimens for multidrug-resistant tuberculosis.Ìý (2019) McHugh, T. D., I. Honeyborne, M. Lipman and A. ZumlaÌý Lancet Infect Dis 19(3): 233-234 (19)30060-X.

Riboswitches: choosing the best platform.Ìý (2019) Arnvig, K. B.Ìý Biochem Soc Trans 47(4): 1091-1099 .

Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children-A Systematic Review and Meta-Analysis.Ìý (2019) Meier, N. R., T. Volken, M. Geiger, U. Heininger, M. Tebruegge and N. RitzÌý Front Pediatr 7: 208 .

The Risk of Falsely Declaring Non-Inferiority of Novel Latent Tuberculosis Treatment in Large Trials.Ìý (2019) Abubakar, I., F. G. Cobelens and M. X. RangakaÌý Am J Respir Crit Care Med .

Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB-rifampicin sensitivity among Ugandan patients.Ìý (2019) Mukonzo, J. K., A. Kengo, B. Kutesa, S. Nanzigu, A. Pohanka, T. D. McHugh, A. Zumla and E. AklilluÌý Trans R Soc Trop Med Hyg .

Screening the population: Public information films in Scandinavian tuberculosis campaigns around 1950.Ìý (2019) Thomson, C.Ìý Journal of Scandinavian Cinema 9(1): 59-74 .

A Shorter Regimen for Rifampin-Resistant Tuberculosis. Reply.Ìý (2019) Nunn, A. J. and P. P. J. PhillipsÌý N Engl J Med 381(11): e22 .

Should NICE reconsider the 2016 UK guidelines on TB contact tracing? A cost-effectiveness analysis of contact investigations in London.Ìý (2019) Cavany, S. M., E. Vynnycky, C. S. Anderson, H. Maguire, F. Sandmann, H. L. Thomas, R. G. White and T. SumnerÌý Thorax 74(2): 185-193 .

Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.Ìý (2019) Story, A., R. W. Aldridge, C. M. Smith, E. Garber, J. Hall, G. Ferenando, L. Possas, S. Hemming, F. Wurie, S. Luchenski, I. Abubakar, T. D. McHugh, P. J. White, J. M. Watson, M. Lipman, R. Garfein and A. C. HaywardÌý Lancet 393(10177): 1216-1224 (18)32993-3.

Socio-demographic contributors to health and safety of mine workers in South Africa.Ìý (2019) Pelders, J. and G. NelsonÌý Work 64(1): 67-76 .

Space-time clustering of recently-diagnosed tuberculosis and impact of ART scale-up: Evidence from an HIV hyper-endemic rural South African population.Ìý (2019) Tomita, A., C. M. Smith, R. J. Lessells, A. Pym, A. D. Grant, T. de Oliveira and F. TanserÌý Sci Rep 9(1): 10724 .

Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing.Ìý (2019) Dheda, K., L. Lenders, S. Srivastava, G. Magombedze, H. Wainwright, P. Raj, S. J. Bush, G. Pollara, R. Steyn, M. Davids, A. Pooran, T. Pennel, A. Linegar, R. McNerney, L. Moodley, J. G. Pasipanodya, C. T. Turner, M. Noursadeghi, R. M. Warren, E. Wakeland and T. GumboÌý Am J Respir Crit Care Med 200(3): 370-380 .

A sputum sample processing method for community and mobile tuberculosis diagnosis using the Xpert MTB/RIF assay.Ìý (2019) Gliddon, H. D., R. J. Shorten, A. C. Hayward and A. StoryÌý ERJ Open Res 5(1) .

STREAM: a pragmatic and explanatory trial for MDR-TB treatment.Ìý (2019) Abubakar, I., S. Meredith, A. J. Nunn, P. P. J. Phillips and I. D. RusenÌý Lancet Infect Dis 19(6): 575-576 (19)30215-4.

Studies on patients establish Crohn's disease as a manifestation of impaired innate immunity.Ìý (2019) Segal, A. W.Ìý J Intern Med 286(4): 373-388 .

A Systematic Review and Meta-analysis of the Diagnostic Accuracy of Nucleic Acid Amplification Tests for Tuberculous Meningitis.Ìý (2019) Pormohammad, A., M. J. Nasiri, T. D. McHugh, S. M. Riahi and N. C. BahrÌý J Clin Microbiol 57(6) .

Towards a Future of Rapid, Low-Cost, Multiplexed Detection of Antimicrobial Resistance Markers for Tuberculosis and Other Pathogens.Ìý (2019) Miller, B. S., H. D. Gliddon and R. A. McKendryÌý Clin Chem 65(3): 367-369 .

Towards optimal treatment for latent Mycobacterium tuberculosis infection.Ìý (2019) Abubakar, I., J. Chakaya, M. Maeurer and A. ZumlaÌý Lancet Respir Med 7(3): 195-197 (19)30036-0.

Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status.Ìý (2019) Tweed, C. D., A. M. Crook, R. Dawson, A. H. Diacon, T. D. McHugh, C. M. Mendel, S. K. Meredith, L. Mohapi, M. E. Murphy, A. J. Nunn, P. P. J. Phillips, K. P. Singh, M. Spigelman and S. H. GillespieÌý BMC Pulm Med 19(1): 152 .

Transmission of drug-resistant tuberculosis in HIV-endemic settings.Ìý (2019) Khan, P. Y., T. A. Yates, M. Osman, R. M. Warren, Y. van der Heijden, N. Padayatchi, E. A. Nardell, D. Moore, B. Mathema, N. Gandhi, V. Eldholm, K. Dheda, A. C. Hesseling, V. Mizrahi, R. Rustomjee and A. PymÌý Lancet Infect Dis 19(3): e77-e88 .

TRAV1-2(+) CD8(+) T-cells including oligoconal expansions of MAIT cells are enriched in the airways in human tuberculosis.Ìý (2019) Wong, E. B., M. C. Gold, E. W. Meermeier, B. Z. Xulu, S. Khuzwayo, Z. A. Sullivan, E. Mahyari, Z. Rogers, H. Kloverpris, P. K. Sharma, A. H. Worley, U. Lalloo, P. Baijnath, A. Ambaram, L. Naidoo, M. Suleman, R. Madansein, J. E. McLaren, K. Ladell, K. L. Miners, D. A. Price, S. M. Behar, M. Nielsen, V. O. Kasprowicz, A. Leslie, W. R. Bishai, T. Ndung'u and D. M. LewinsohnÌý Commun Biol 2(1): 203 .

Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data.Ìý (2019) Pedrazzoli, D., K. Kranzer, H. L. Thomas and M. K. LalorÌý ERJ Open Res 5(4) .

A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis.Ìý (2019) Nunn, A. J., P. P. J. Phillips, S. K. Meredith, C. Y. Chiang, F. Conradie, D. Dalai, A. van Deun, P. T. Dat, N. Lan, I. Master, T. Mebrahtu, D. Meressa, R. Moodliar, N. Ngubane, K. Sanders, S. B. Squire, G. Torrea, B. Tsogt, I. D. Rusen and S. S. CollaboratorsÌý N Engl J Med 380(13): 1201-1213 .

Tuberculin skin test - Outdated or still useful for Latent TB infection screening?Ìý (2019) Gualano, G., P. Mencarini, F. N. Lauria, F. Palmieri, S. Mfinanga, P. Mwaba, J. Chakaya, A. Zumla and G. IppolitoÌý Int J Infect Dis 80S: S20-S22 .

Tuberculosis and leprosy associated with historical human population movements in Europe and beyond - an overview based on mycobacterial ancient DNA.Ìý (2019) Donoghue, H. D.Ìý Ann Hum Biol 46(2): 120-128 .

Tuberculosis disease in children and adolescents on therapy with anti-tumor necrosis factor-alpha agents: a collaborative, multi-centre ptbnet study.Ìý (2019) Noguera-Julian, A., J. Calzada-HernAndez, F. Brinkmann, R. Basu Roy, O. Bilogortseva, M. Buettcher, I. Carvalho, V. Chechenyeva, L. Falcon, F. Goetzinger, C. Guerrero-Laleona, P. Hoffmann, M. Jelusic, T. Niehues, I. Ozere, F. Shackley, E. Suciliene, S. B. Welch, O. E. H. Sch, N. Ritz and M. TebrueggeÌý Clin Infect Dis .

Tuberculosis following renal transplantation in England, Wales and Northern Ireland: a national registry-based cohort study.Ìý (2019) Gupta, R. K., G. Rosenberg, J. Eriksen, M. Lipman, C. Jackson, A. Roy, D. Zenner, C. Smith, M. Harber, C. Campbell and I. AbubakarÌý Eur Respir J 54(4) .

Tuberculosis Genetic Epidemiology: A Latin American Perspective.Ìý (2019) Woodman, M., I. L. Haeusler and L. GrandjeanÌý Genes (Basel) 10(1) .

The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation.Ìý (2019) van Leth, F., F. Brinkmann, D. M. Cirillo, K. Dheda, R. Duarte, L. Guglielmetti, L. Kuksa, C. Lange, C. Mitnick, A. Skrahina, K. Zaman and G. BothamleyÌý Eur Respir J 53(1) .

Urogenital tuberculosis - epidemiology, pathogenesis and clinical features.Ìý (2019) Muneer, A., B. Macrae, S. Krishnamoorthy and A. ZumlaÌý Nat Rev Urol 16(10): 573-598 .

Whole genome sequencing Mycobacterium tuberculosis directly from sputum identifies more genetic diversity than sequencing from culture.Ìý (2019) Nimmo, C., L. P. Shaw, R. Doyle, R. Williams, K. Brien, C. Burgess, J. Breuer, F. Balloux and A. S. PymÌý BMC Genomics 20(1): 389 .

Correction to: Whole genome sequencing Mycobacterium tuberculosis directly from sputum identifies more genetic diversity than sequencing from culture.Ìý (2019) Nimmo, C., L. P. Shaw, R. Doyle, R. Williams, K. Brien, C. Burgess, J. Breuer, F. Balloux and A. S. PymÌý BMC Genomics 20(1): 433 .

World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme Series.Ìý (2019) Petersen, E., M. Rao, G. Ippolito, G. Gualano, J. Chakaya, F. Ntoumi, D. Moore, R. Allen, K. Gaskell, J. N. Ohd, M. P. Hergens, S. Krishnamoorthy, C. Ugarte-Gil, D. E. Kirwan, I. Honeyborne, T. D. McHugh, C. U. Koser, K. Kranzer, S. Tiberi, G. B. Migliori, Q. Mao, Y. Yang, S. P. Oliveira, R. F. Cardoso, A. Detjen, B. Marais, D. de Gijsel, C. F. von Reyn, L. Gosce, I. Abubakar, M. Maeurer and A. ZumlaÌý Int J Infect Dis 80S: S1-S5 .

Xpert MTB/RIF Ultra for Tuberculosis Testing in Children: A Mini-Review and Commentary.Ìý (2019) Atherton, R. R., F. V. Cresswell, J. Ellis, S. B. Kitaka and D. R. BoulwareÌý Front Pediatr 7: 34 .

Ìý

Other Outputs

Reports:Ìý

Clinic-level variations in contact tracing outcomes: protocol for a cross-sectional study of variation and case-mix adjustment in London, UK. Lewer, D; Tamne, S; Nicholas, O; Anderson, C; Story, A; (2019)Ìý ¹û¶³Ó°Ôº Collaborative Centre for Inclusion Health: London, UK.

Workshops:

India-UK Networking Partnership Workshops (Chennai and Delhi) February 2019 (Sarah Pett, MRC CTU at ¹û¶³Ó°Ôº, s.pett@ucl.ac.uk).

View workshop programme

View workshop programme

Blogs:

. 06 April 2019. N.G. Stoker

. May 2019. N.G. Stoker

Go to Top